Tamai Mizuki, Harada Kyoichi, Takemoto Kenichi, Koshino Katsuhiro, Naito Kei, Ochiai Toshiya, Otsuji Eigo
Dept. of Surgery, North Medical Center Kyoto Prefectural University of Medicine.
Gan To Kagaku Ryoho. 2022 Dec;49(13):1968-1970.
We report 3 cases of cholangiolocellular carcinoma(CoCC)experienced from April 2017 to March 2021 in our hospital. The average age of the cases is 74.3 years old, 2 males and 1 female respectively. Hepatectomy was performed in 2 cases, and transcatheter arterial embolization(TAE)and radiofrequency ablation(RFA)therapy was performed in 1 case because of old age and his wishes as the background liver disease. Chronic hepatitis C was found in 1 case, fatty liver in 1 case, and alcoholic liver disease in 1 case. Two patients who underwent hepatectomy had good long-term prognosis, but another patient who underwent TAE and RFA developed early recurrence at bone and died in 3 months after treatment. Therefore, we consider that the risk of recurrence should be examined and the treatment should be performed accordingly.
我们报告了2017年4月至2021年3月期间我院收治的3例胆管细胞癌（CoCC）病例。病例的平均年龄为74.3岁，分别为2例男性和1例女性。2例行肝切除术，1例因年龄较大且鉴于基础肝病患者意愿而行经导管动脉栓塞术（TAE）和射频消融术（RFA）治疗。1例发现慢性丙型肝炎，1例为脂肪肝，1例为酒精性肝病。2例行肝切除术的患者长期预后良好，但另1例行TAE和RFA治疗的患者骨早期复发，并在治疗后3个月死亡。因此，我们认为应检查复发风险并相应地进行治疗。
